scorecardresearch
Add as a preferred source on Google
Sunday, February 22, 2026
TopicZydus Cadila

Topic: Zydus Cadila

2 months after vaccine approval, Covid shots for kids stuck on list of comorbidities, procedure

Zycov-D is the lone vaccine cleared for use in children in India. However, expert panel still thrashing out some issues to streamline the rollout for parents.

Modi govt drives hard bargain, ZyCov-D vaccine could cost Rs 275/dose or even less

The world’s first DNA vaccine for Covid manufactured by Gujarat-based Zydus Cadila is delivered using a special applicator costing Rs 30,000.

Vaccine makers upset over ‘differential pricing’ for ZyCov-D, and lack of clarity on exports

ZyCov-D has reportedly been priced by the company at Rs 1,900 for three doses while the others cost between Rs 205-215 per dose.

6 shots per patient, Rs 30,000 applicator gun complicate govt talks for ZyCov-D vaccine

World's first DNA vaccine, ZyCov-D is a 3-dose vaccine (administered in 2 injections each time) which requires a special needle-free applicator.

ZyCov-D price talks still on, but India begins training for use of needle-free applicator

First instalment of ZyCov-D, a three-dose Covid vaccine manufactured by Zydus Cadila, is expected next month. Vaccine doesn't require a needle injection to be administered.

Zycov D is 66% effective against Delta variant of SARS-Cov-2, claims Zydus Cadila

Zydus' claim comes a day after it being given emergency use authorisation in India, and is the only vaccine approved for use in 12-18 years age group.

Three-dose ZyCoV-D vaccine could be just two doses, says pharma firm Zydus Cadila

Zydus Cadilla says its test data shows that the vaccine appears to be just as effective in 2 doses as 3, and will be administered 28 days apart.

Zydus Cadila applies for approval to ZyCov-D, India’s 1st Covid vaccine tested on 12-18-yr-olds

If ZyCov-D gets the approval, it will be the fifth vaccine authorised for use in India after Covishield, Covaxin, Sputnik V and Moderna.

India’s ZyCoV-D set to become world’s first DNA Covid vaccine as govt approval likely soon

Gujarat-based Zydus Cadila has told Modi govt that it could apply for emergency use authorisation for ZyCoV-D vaccine in the next 10-12 days.

Zydus’s antiviral drug Virafin gets emergency approval to treat moderate Covid patients

In statement, Zydus Cadila says phase 3 clinical trial data showed Virafin reduced oxygen requirement in patients, & and that a significant number of them tested negative by 7th day.

On Camera

Patel’s 1950 letter to Nehru: Find no legal power to deal with Press or men like Syama Prasad

Less than a year before the First Constitutional Amendment, Patel wrote to Nehru about Supreme Court rulings that had 'knocked the bottom out' of press control laws.

In the West, there’s anxiety. In India, optimism—Rishi Sunak says India poised to be leader in AI

On Wednesday, the former UK Prime Minister Rishi Sunak was speaking in New Delhi at a Carnegie & Observer Research Foundation event on AI.

MoD, IAF agree on some exemptions to HAL for Tejas Mk1A, but no compromise on ‘must-have’ capabilities

IAF is fine with accepting the aircraft with 'must-haves', even if some other steps remain pending, which may take at least another year, it is learnt.

No country is ever fully sovereign. Cold War era taught India its real meaning

India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.